The Food and Drug Administration has approved a new blood test to help identify signs of Alzheimer’s disease for people 55 and older who are already showing signs of cognitive decline. The test, from pharmaceutical company Roche and partner Eli Lilly, is a bio-marker blood test. The Food and Drug Administration has approved a new blood test to help identify signs of Alzheimer’s disease for people 55 and older who are already showing signs of cognitive decline. The test, from pharmaceutical company Roche and partner Eli Lilly, is a bio-marker blood test.
FDA Approves New Blood Test to Identify Signs of Alzheimer’sFDA Approves New Blood Test to Identify Signs of Alzheimer’s
